Assistance Publique - Hôpitaux de Paris: Scleroderma, Diffuse trials
The registry lists 13 Scleroderma, Diffuse studies with Assistance Publique - Hôpitaux de Paris as lead sponsor. 4 are open to participants now and 0 have results posted.
Phase 1 2Phase 2 3Phase 3 3No phase 8(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Clinical Study on Systemic Sclerosis and the Validation of French-language Questionnaires Assessing Disability, Quality of Life, and Disease Status.Not yet recruitingNCT07888842
- Phase I/II Randomized Clinical Trial of Allogeneic Adipose Tissue-derived Mesenchymal Stromal Cells Systemic Infusion in Severe Systemic SclerosisNot yet recruitingNCT06722105Phase 1/2
- Acceptance and Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) Vaccination in Systemic Sclerosis Patients Treated by Autologous Hematopoietic Stem Cell TransplantationNot yet recruitingNCT05960058
- Manufacturing of Allogeneic Adipose Tissue-derived Mesenchymal Stromal Cells for Treatment of Severe Systemic SclerosisNot yet recruitingNCT05947682Not applicable
- Phenotyping of Chronic Pain in Diffused Systemic SclerodermaCompletedNCT05622578Not applicable
- Study of the Intestinal Microbiota of Patients With Systemic SclerosisStatus unknownNCT04791280
- Efficacy of Botulinum Toxin A in Adult Subjects With Raynaud Phenomenon Secondary to Systemic SclerosisCompletedNCT03717961Phase 3
- MRI Quantification of Pulmonary Fibrosis in Scleroderma PatientsCompletedNCT03207997Not applicable
- Pregnancy and Medically Assisted Conception in Rare DiseasesWithdrawnNCT02450396
- Treatment of Refractory Sever Systemic Scleroderma by Injection of Allogeneic Mesenchymal Stem CellsCompletedNCT02213705Phase 1/2
- Rituximab in Systemic SclerosisCompletedNCT01748084Phase 2/3
- Cyclophosphamide Systemic Sclerosis Associated Interstitial Lung DiseaseCompletedNCT01570764Phase 3
- Effects of a Personalized Standardized Rehabilitation Program in Systemic SclerosisCompletedNCT00318188Not applicable